• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013年挪威的心肌梗死情况。

Myocardial infarction in Norway in 2013.

作者信息

Jortveit Jarle, Govatsmark Ragna Elise Støre, Digre Tormod Aarlott, Risøe Cecilie, Hole Torstein, Mannsverk Jan, Slørdahl Stig Arild, Halvorsen Sigrun

机构信息

Kardiologisk avdeling Hjerteseksjonen Medisinsk avdeling Sørlandet sykehus Arendal.

Kardiologisk avdeling Norsk hjerteinfarktregister St. Olavs hospital.

出版信息

Tidsskr Nor Laegeforen. 2014 Oct 14;134(19):1841-6. doi: 10.4045/tidsskr.14.0804.

DOI:10.4045/tidsskr.14.0804
PMID:25314984
Abstract

BACKGROUND

The Norwegian Myocardial Infarction Registry was established in 2012 as a national quality registry. This first report from the registry presents the number of myocardial infarctions, the treatment provided and the 30-day mortality rate for myocardial infarctions admitted to Norwegian hospitals.

MATERIAL AND METHOD

All patients with myocardial infarction admitted to Norwegian hospitals in 2013 and recorded in the Norwegian Myocardial Infarction Registry are included. The number of myocardial infarctions, patient characteristics and their treatment are indicated for myocardial infarctions with and without ST-segment elevation on ECG (STEMI and nSTEMI). The 30-day mortality is calculated for each health region.

RESULTS

In 2013, a total of 13,043 myocardial infarctions in 12,336 patients were recorded in the Norwegian Myocardial Infarction Registry. Altogether 3,658 (28%) of the infarctions were classified as STEMI and 9,188 (70%) as nSTEMI. The average age at the time of the infarction was 68.1 years for men and 75.9 years for women. Percutaneous coronary intervention was performed for a total of 2,798 (77%) ST-segment elevation myocardial infarctions, whereas the corresponding number for nSTEMI was 3,179 (35%). The 30-day mortality in the entire infarction population was 10% (< 60 years: 2%, 60-69 years: 4%, 70-79 years: 9%, ≥ 80 years: 20%). We found no differences in mortality between health regions or between men and women.

INTERPRETATION

This first report from the Norwegian Myocardial Infarction Registry shows that the treatment service is functioning well for most patients. Secondary prophylaxis using drug therapy and increased use of invasive examination of patients with nSTEMI appear to be areas for improvement.

摘要

背景

挪威心肌梗死登记处成立于2012年,是一个全国性的质量登记处。该登记处的首份报告展示了挪威医院收治的心肌梗死病例数、所提供的治疗以及心肌梗死患者的30天死亡率。

材料与方法

纳入2013年挪威医院收治并记录在挪威心肌梗死登记处的所有心肌梗死患者。记录有ST段抬高和无ST段抬高心电图表现的心肌梗死(ST段抬高型心肌梗死和非ST段抬高型心肌梗死)的心肌梗死病例数、患者特征及其治疗情况。计算每个健康区域的30天死亡率。

结果

2013年,挪威心肌梗死登记处共记录了12336例患者的13043例心肌梗死病例。其中,3658例(28%)梗死被分类为ST段抬高型心肌梗死,9188例(70%)为非ST段抬高型心肌梗死。梗死发生时男性的平均年龄为68.1岁,女性为75.9岁。共对2798例(77%)ST段抬高型心肌梗死患者进行了经皮冠状动脉介入治疗,而非ST段抬高型心肌梗死患者的相应治疗例数为3179例(35%)。整个梗死人群的30天死亡率为10%(<60岁:2%,60 - 69岁:4%,70 - 79岁:9%,≥80岁:20%)。我们发现健康区域之间以及男性和女性之间在死亡率上没有差异。

解读

挪威心肌梗死登记处的这份首份报告表明,治疗服务对大多数患者运作良好。使用药物进行二级预防以及增加对非ST段抬高型心肌梗死患者的侵入性检查似乎是有待改进的领域。

相似文献

1
Myocardial infarction in Norway in 2013.2013年挪威的心肌梗死情况。
Tidsskr Nor Laegeforen. 2014 Oct 14;134(19):1841-6. doi: 10.4045/tidsskr.14.0804.
2
Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.对于急性心肌梗死患者,既往心肌梗死的影响。
Am Heart J. 2014 Jun;167(6):840-5. doi: 10.1016/j.ahj.2014.03.009. Epub 2014 Apr 3.
3
Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.有或没有导管实验室的医院收治的急性心肌梗死患者的结局:来自HELIOS注册研究的结果。
Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):85-90. doi: 10.1097/HJR.0b013e32831e954e.
4
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.院前溶栓治疗对急性心肌梗死1年预后的影响:来自法国全国性USIC 2000注册研究的结果
Circulation. 2004 Oct 5;110(14):1909-15. doi: 10.1161/01.CIR.0000143144.82338.36. Epub 2004 Sep 27.
5
The chain of survival for ST-segment elevation myocardial infarction: insights into the Middle East.ST段抬高型心肌梗死的生存链:对中东地区的见解
Crit Pathw Cardiol. 2013 Sep;12(3):154-60. doi: 10.1097/HPC.0b013e3182901f28.
6
Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.在六个中东国家中,对 ACC/AHA 心肌梗死绩效指标的遵守情况与住院死亡率和临床特征的关系。
Int J Cardiol. 2013 Aug 20;167(4):1406-11. doi: 10.1016/j.ijcard.2012.04.066. Epub 2012 May 10.
7
Short-term and long-term mortality associated with ventricular arrhythmia in patients hospitalized with acute coronary syndrome: findings from the Gulf RACE registry-2.急性冠脉综合征住院患者室性心律失常相关的短期和长期死亡率:海湾RACE注册研究-2的结果
Coron Artery Dis. 2013 Mar;24(2):160-4. doi: 10.1097/MCA.0b013e32835c49ed.
8
[Comparison of the clinical characteristics and hospital treatment of myocardial infarction with and without ST-segment elevation in Hungary. National Registry of Myocardial Infarction].[匈牙利ST段抬高型与非ST段抬高型心肌梗死的临床特征及住院治疗比较。国家心肌梗死登记处]
Orv Hetil. 2014 May 25;155(21):828-32. doi: 10.1556/OH.2014.29843.
9
Outcomes of invasive treatment in very elderly Polish patients with non-ST-segment-elevation myocardial infarction from 2003-2009 (from the PL-ACS registry).2003-2009 年波兰非 ST 段抬高型心肌梗死超高龄患者的介入治疗结果(来自 PL-ACS 注册研究)。
Cardiol J. 2013;20(1):34-43. doi: 10.5603/CJ.2013.0007.
10
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.非标准可调节风险因素的 STEMI 患者的死亡率:SWEDEHEART 注册研究数据的性别细分分析。
Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9.

引用本文的文献

1
Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: a nationwide cohort study 2013-22.急性心肌梗死合并心脏骤停患者的短期和长期预后:一项2013 - 2022年的全国性队列研究
Eur Heart J Acute Cardiovasc Care. 2024 Dec 24;13(12):828-837. doi: 10.1093/ehjacc/zuae121.
2
Exploring variation in timely reperfusion treatment in ST-segment elevation myocardial infarction in Norway: a national register-based cohort study.探讨挪威 ST 段抬高型心肌梗死患者及时再灌注治疗的差异:一项基于全国登记的队列研究。
BMJ Open. 2024 Feb 17;14(2):e081301. doi: 10.1136/bmjopen-2023-081301.
3
A risk model for the early diagnosis of acute myocardial infarction in patients with chronic kidney disease.
一种用于慢性肾脏病患者急性心肌梗死早期诊断的风险模型。
Front Cardiovasc Med. 2023 Oct 10;10:1253619. doi: 10.3389/fcvm.2023.1253619. eCollection 2023.
4
Timing of angiography and outcomes in patients with non-ST-segment elevation myocardial infarction: Insights from the evaluation and management of patients with acute chest pain in China registry.非ST段抬高型心肌梗死患者血管造影的时机与预后:来自中国急性胸痛患者评估与管理注册研究的见解
Front Cardiovasc Med. 2022 Oct 20;9:1000554. doi: 10.3389/fcvm.2022.1000554. eCollection 2022.
5
Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19.2013 - 2019年挪威急性心肌梗死的发病率、治疗情况及预后的时间趋势。
Eur Heart J Open. 2022 Aug 10;2(5):oeac052. doi: 10.1093/ehjopen/oeac052. eCollection 2022 Sep.
6
Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction.房颤和心肌梗死患者抗凝治疗依从指南推荐的时间趋势。
Open Heart. 2022 Apr;9(1). doi: 10.1136/openhrt-2021-001934.
7
Feasibility of prehospital identification of non-ST-elevation myocardial infarction by ECG, troponin and echocardiography.心电图、肌钙蛋白和超声心动图在院前识别非 ST 段抬高型心肌梗死的可行性。
Emerg Med J. 2022 Sep;39(9):679-684. doi: 10.1136/emermed-2021-211179. Epub 2022 Jan 21.
8
Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway.挪威 ST 段抬高型心肌梗死患者延迟直接经皮冠状动脉介入治疗与药物侵入性策略的结果。
Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):442-451. doi: 10.1093/ehjcvp/pvab041.
9
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox.非 ST 段抬高型心肌梗死患者的侵入性治疗和抗血小板治疗:理解和解决全球风险-治疗悖论。
Clin Cardiol. 2019 Oct;42(10):1028-1040. doi: 10.1002/clc.23232. Epub 2019 Jul 17.
10
Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease.心肌梗死和既往有冠状动脉疾病患者的危险因素控制不佳及新发心血管事件发生率高。
BMC Cardiovasc Disord. 2019 Mar 28;19(1):71. doi: 10.1186/s12872-019-1062-y.